- Since the beginning of pandemic, Germany has recorded over two million COVID-19 cases.
- More than 50,000 people died in Germany due to coronavirus.
- Germany is the first EU country to use medicines that were used to treat Donald Trump’s COVID-19 infection.
- The treatment included two different kinds of so-called monoclonal antibody therapies.
- The new treatment is now available to university hospitals.
Germany has become the first European Union (EU) country to use the same experimental antibodies that were used for the medical treatment of Former United States (US) President Donald Trump. German Health minister Jens Spah confirmed the same in the official statement. Trump has successfully recovered from COVID-19.
The minister told media that the German government had bought 200,000 doses for 400 million euros (equal to US $ 486 million). The price of one dose was 2000 euros (equal to $ 2396.57). Patients are receiving these doses free of charge. Germany has purchased doses of American firm Regeneron’s Casirivimab/Imdevimab antibody cocktail, along with American company Eli Lilly’s Bamlanivimab antibody drug.
Administering this medical treatment involves two different kinds of monoclonal antibody therapies which are available to university hospitals. The treatment have been approved for emergency use in the United States of America (USA). EU is yet to approve it.
The ministry spokeswoman said the Paul Ehrlich Institute (PIE), Germany’s national regulator, had determined that the use of drugs was “in principle” allowed on a case-by-case basis. Administering the treatment would be decided by doctors to prevent “severe illness or hospitalizations among certain risk groups”.